rs144717862
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 0P and 3B. BP4_ModerateBP6
The NM_004006.3(DMD):c.5208C>A(p.Asp1736Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000745 in 1,208,785 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004006.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DMD | NM_004006.3 | c.5208C>A | p.Asp1736Glu | missense_variant | 37/79 | ENST00000357033.9 | NP_003997.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DMD | ENST00000357033.9 | c.5208C>A | p.Asp1736Glu | missense_variant | 37/79 | 1 | NM_004006.3 | ENSP00000354923 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000451 AC: 5AN: 110828Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33046
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 183080Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67614
GnomAD4 exome AF: 0.00000364 AC: 4AN: 1097901Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 1AN XY: 363293
GnomAD4 genome AF: 0.0000451 AC: 5AN: 110884Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33112
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 02, 2015 | The p.Asp1736Glu variant in DMD has not been previously reported in individuals with cardiomyopathy, but has been identified in 1/8394 African chromosomes by th e Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs14 4717862). Aspartic acid (Asp) at position 1736 is conserved in mammals but not i n evolutionarily distant species, and Xenopus tropicalis carries a glutamic acid (Glu) at this position, raising the possibility that this change may be tolerat ed. However, this information is not predictive enough to rule out pathogenicity . In summary, the clinical significance of the p.Asp1736Glu variant is uncertain . - |
Duchenne muscular dystrophy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 15, 2023 | This sequence change replaces aspartic acid, which is acidic and polar, with glutamic acid, which is acidic and polar, at codon 1736 of the DMD protein (p.Asp1736Glu). This variant is present in population databases (rs144717862, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with DMD-related conditions. ClinVar contains an entry for this variant (Variation ID: 228591). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt DMD protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 21, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at